Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 300 Companies   483 Products   483 Products   198 Mechanisms of Action   25 Trials   7711 News 


«12...910111213141516171819...156157»
  • ||||||||||  Enrollment change, Trial withdrawal:  Excia T Cementless EBRA Study (clinicaltrials.gov) -  Sep 7, 2017   
    P=N/A,  N=0, Withdrawn, 
    Initiation date: Jun 2017 --> Oct 2017 | Trial primary completion date: Jan 2019 --> Oct 2019 N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Phase classification:  Overnight Closed Loop Study in U.S. (clinicaltrials.gov) -  Sep 1, 2017   
    P=N/A,  N=78, Completed, 
    Recruiting --> Active, not recruiting Phase classification: P2 --> P=N/A
  • ||||||||||  Enrollment change, Trial primary completion date:  International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol (clinicaltrials.gov) -  Sep 1, 2017   
    P=N/A,  N=100, Recruiting, 
    Phase classification: P1/2 --> P=N/A | N=50 --> 0 | Recruiting --> Withdrawn N=20 --> 100 | Trial primary completion date: Feb 2017 --> Oct 2017
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Trial completion, Enrollment change, Trial primary completion date, MRI:  A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients (clinicaltrials.gov) -  Aug 30, 2017   
    P1,  N=8, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=12 --> 8 | Trial primary completion date: Dec 2017 --> Aug 2017
  • ||||||||||  DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
    Trial completion:  Post Marketing Surveillance (PMS) Study of Ryzodeg (clinicaltrials.gov) -  Aug 28, 2017   
    P=N/A,  N=1029, Completed, 
    Trial primary completion date: Jan 2018 --> May 2018 Active, not recruiting --> Completed
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy (clinicaltrials.gov) -  Aug 28, 2017   
    P=N/A,  N=28, Terminated, 
    N=60 --> 28 | Recruiting --> Terminated | Trial primary completion date: Jan 2018 --> Jun 2017; All Parkinson's disease patients have finished training. The MS and ECT groups have not finished as these groups had trouble including 20 patients.
  • ||||||||||  Enrollment closed, Trial initiation date, Trial primary completion date:  Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis (clinicaltrials.gov) -  Aug 28, 2017   
    P=N/A,  N=30, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2017 --> Dec 2016 Recruiting --> Active, not recruiting | Initiation date: Oct 2016 --> Feb 2017 | Trial primary completion date: Jun 2017 --> Jan 2018
  • ||||||||||  Trial completion, Trial primary completion date:  A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS) (clinicaltrials.gov) -  Aug 23, 2017   
    P=N/A,  N=54, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jun 2017 Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jun 2017
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Phase classification, Surgery:  Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=170, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jun 2017 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, HEOR:  Effect of Active-Passive Trainer Cycling on Multiple Sclerosis (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=24, Completed, 
    Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Not yet recruiting --> Completed | N=30 --> 24 | Trial primary completion date: May 2017 --> Jul 2017
  • ||||||||||  Trial primary completion date:  Resistance Exercise in Rheumatic Disease (clinicaltrials.gov) -  Aug 18, 2017   
    P=N/A,  N=10, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jul 2016 --> Jul 2018
  • ||||||||||  Trial completion, Trial primary completion date, IO biomarker:  Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) -  Aug 14, 2017   
    P=N/A,  N=629, Completed, 
    Active, not recruiting --> Terminated | Trial primary completion date: Apr 2018 --> Jul 2017; Study was terminated by sponsor and decision was not due to any safety signals. Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jul 2014
  • ||||||||||  bortezomib / Generic mfg.
    Trial completion, Enrollment change:  Pilot Study of Velcade (clinicaltrials.gov) -  Aug 10, 2017   
    P4,  N=11, Completed, 
    N=30 --> 37 | Trial primary completion date: Jun 2018 --> Sep 2018 Recruiting --> Completed | N=15 --> 11
  • ||||||||||  Trial completion, Enrollment change:  GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) -  Aug 10, 2017   
    P=N/A,  N=250, Completed, 
    Recruiting --> Completed | N=15 --> 11 Recruiting --> Completed | N=200 --> 250
  • ||||||||||  Enrollment change, Trial withdrawal:  DiaCon Dual-Hormone Closed-Loop Glucose Control (clinicaltrials.gov) -  Aug 9, 2017   
    P2/3,  N=0, Withdrawn, 
    Recruiting --> Completed | N=200 --> 250 N=13 --> 0 | Not yet recruiting --> Withdrawn